Search research articles
Contact Us
Filters
Showing results (81-90 of 241) with videos related to
Page
of 25
Sort By:
Journal of Pharmacy & Bioallied Sciences
|
March 19, 2026
Efficacy of QMix with Canal Brush for Removal of Debris and Smear Layer in Root Canals Instrumented with ProTaper Next and WaveOne File
R Ambika Kumari, Vishwas Sangappa Madhudi, Alan Winston David, et al.
Journal of Pharmacy & Bioallied Sciences
|
March 10, 2025
Comparative Evaluation of Microleakage of Glass Ionomer and Glass Ionomer with Ethanolic Extract of Propolis - An <i>In Vitro</i> Study
Deepti V Balehosur, Jasmine Mary Antony, Deeksha Sharma, et al.
Npj Aging
|
September 23, 2025
Mitochondrial respiratory chain deficiency is associated with an impaired skeletal muscle regenerative response and fibrosis in older men with HIV
Matthew Hunt, Amy E Vincent, Megan M McNiff, et al.
Brain Sciences
|
August 14, 2019
Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART
Jaime H Vera, Margherita Bracchi, Jasmini Alagaratnam, et al.
BMJ Neurology Open
|
July 5, 2021
Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
Jasmini Alagaratnam, Sophia von Widekind, Davide De Francesco, et al.
AIDS (London, England)
|
July 27, 2013
Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART
Lucy J Garvey, Nicola Pavese, Marios Politis, et al.
Plos One
|
June 4, 2026
The role of premorbid cognitive performance in the neuropsychological assessment of people with HIV in South Africa
Anna J Dreyer, John A Joska, Kevin G F Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 19, 2015
Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance
Kathleen A M Rose, Jaime H Vera, Peter Drivas, et al.
AIDS Research and Human Retroviruses
|
December 7, 2010
Changes in cerebral function parameters in HIV type 1-infected subjects switching to darunavir/ritonavir either as monotherapy or with nucleoside analogues
Lucy Garvey, Chris Higgs, Perry Mohammed, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 2013
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
Borja Mora-Peris, Adam Croucher, Laura J Else, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 241) with videos related to
Sort By:
Page
of 25
Journal of Pharmacy & Bioallied Sciences
|
March 19, 2026
Efficacy of QMix with Canal Brush for Removal of Debris and Smear Layer in Root Canals Instrumented with ProTaper Next and WaveOne File
R Ambika Kumari, Vishwas Sangappa Madhudi, Alan Winston David, et al.
Journal of Pharmacy & Bioallied Sciences
|
March 10, 2025
Comparative Evaluation of Microleakage of Glass Ionomer and Glass Ionomer with Ethanolic Extract of Propolis - An <i>In Vitro</i> Study
Deepti V Balehosur, Jasmine Mary Antony, Deeksha Sharma, et al.
Npj Aging
|
September 23, 2025
Mitochondrial respiratory chain deficiency is associated with an impaired skeletal muscle regenerative response and fibrosis in older men with HIV
Matthew Hunt, Amy E Vincent, Megan M McNiff, et al.
Brain Sciences
|
August 14, 2019
Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART
Jaime H Vera, Margherita Bracchi, Jasmini Alagaratnam, et al.
BMJ Neurology Open
|
July 5, 2021
Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
Jasmini Alagaratnam, Sophia von Widekind, Davide De Francesco, et al.
AIDS (London, England)
|
July 27, 2013
Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART
Lucy J Garvey, Nicola Pavese, Marios Politis, et al.
Plos One
|
June 4, 2026
The role of premorbid cognitive performance in the neuropsychological assessment of people with HIV in South Africa
Anna J Dreyer, John A Joska, Kevin G F Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 19, 2015
Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance
Kathleen A M Rose, Jaime H Vera, Peter Drivas, et al.
AIDS Research and Human Retroviruses
|
December 7, 2010
Changes in cerebral function parameters in HIV type 1-infected subjects switching to darunavir/ritonavir either as monotherapy or with nucleoside analogues
Lucy Garvey, Chris Higgs, Perry Mohammed, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 2013
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
Borja Mora-Peris, Adam Croucher, Laura J Else, et al.
Page
of 25